Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,902 | -51,675 | -65,772 | -82,751 | -30,781 |
| Depreciation Amortization | 5,570 | 4,317 | 4,213 | 3,510 | 3,818 |
| Accounts receivable | 1,238 | -14,130 | -7,536 | -2,232 | -3,536 |
| Accounts payable and accrued liabilities | -6,197 | 1,270 | 3,008 | 2,377 | 3,567 |
| Other Working Capital | -1,395 | 2,935 | 2,759 | 354 | -1,092 |
| Other Operating Activity | 6,903 | 15,842 | 10,067 | 8,096 | 2,157 |
| Operating Cash Flow | $-10,783 | $-41,441 | $-53,261 | $-70,646 | $-25,867 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,973 | 18,585 | -2,897 | -15,272 | 3,000 |
| PPE Investments | -1,088 | -1,361 | -2,497 | -3,550 | -1,023 |
| Purchase Sale Intangibles | -59 | -5 | -361 | -500 | 0 |
| Other Investing Activity | -57 | -5 | 2,861 | -500 | 0 |
| Investing Cash Flow | $-9,118 | $17,219 | $-2,533 | $-19,322 | $1,977 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 58,419 | 10,000 |
| Debt Repayment | -8,598 | -8,425 | -989 | -35,229 | -1,654 |
| Common Stock Issued | 11 | 47,292 | 64,560 | 13 | 93,135 |
| Common Stock Repurchased | N/A | N/A | -120 | -61 | -171 |
| Other Financing Activity | -15,160 | -136 | -40 | 415 | 0 |
| Financing Cash Flow | $-9,747 | $38,731 | $63,411 | $23,557 | $101,310 |
| Beginning Cash Position | 46,478 | 31,969 | 24,352 | 90,763 | 13,343 |
| End Cash Position | 16,830 | 46,478 | 31,969 | 24,352 | 90,763 |
| Net Cash Flow | $-29,648 | $14,509 | $7,617 | $-66,411 | $77,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,783 | -41,441 | -53,261 | -70,646 | -25,867 |
| Capital Expenditure | -1,088 | -1,361 | -2,497 | -3,550 | -1,023 |
| Free Cash Flow | -11,871 | -42,802 | -55,758 | -74,196 | -26,890 |